ONPH ONCOLOGY PHARMA INCORPORATED COM NEW: institutional ownership and insider trading
1 funds reported holding $0 of ONCOLOGY PHARMA INCORPORATED COM NEW in their latest 13F filings; in Q2 2026 funds net bought $0, with 1 new positions and 1 funds selling out.